Evidence map›Paper›PMID 29219119›Full record

ArticlePhysics in medicine and biology2018

Density overwrites of internal tumor volumes in intensity modulated proton therapy plans for mobile lung tumors.

Pablo Botas, Clemens Grassberger, Gregory Sharp, Harald Paganetti

Abstract read
In one paragraph

Article in Physics in medicine and biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Advanced proton beam dosimetry part II: Monte CarloTranslational lung cancer research · 2018
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Pablo BotasDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, United States of America.ORCID 0000-0001-7090-9648
Clemens GrassbergerDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, United States of America.
Gregory SharpDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, United States of America.
Harald PaganettiDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, United States of America.
Harvard University · USHeidelberg University · DE

Funding

Statistics, Data Exchange, Management and SupportP01CA021239 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI DELANEY, THOMAS F · 1985 to 2013
$28.3M
MDACC Clinical and Research Physics SupportU19CA021239 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HONG, THEODORE S · 2014 to 2018
$11.2M
NCI NIH HHS P01 CA021239NCI NIH HHS U19 CA021239
6 · The paper itself

Abstract

The purpose of this study was to investigate internal tumor volume density overwrite strategies to minimize intensity modulated proton therapy (IMPT) plan degradation of mobile lung tumors. Four planning paradigms were compared for nine lung cancer patients. Internal gross tumor volume (IGTV) and internal clinical target volume (ICTV) structures were defined encompassing their respective volumes in every 4DCT phase. The paradigms use different planning CT (pCT) created from the average intensity projection (AIP) of the 4DCT, overwriting the density within the IGTV to account for movement. The density overwrites were: (a) constant filling with 100 HU (C100) or (b) 50 HU (C50), (c) maximum intensity projection (MIP) across phases, and (d) water equivalent path length (WEPL) consideration from beam's-eye-view. Plans were created optimizing dose-influence matrices calculated with fast GPU Monte Carlo (MC) simulations in each pCT. Plans were evaluated with MC on the 4DCTs using a model of the beam delivery time structure. Dose accumulation was performed using deformable image registration. Interplay effect was addressed applying 10 times rescanning. Significantly less DVH metrics degradation occurred when using MIP and WEPL approaches. Target coverage ([Formula: see text] Gy(RBE)) was fulfilled in most cases with MIP and WEPL ([Formula: see text] Gy (RBE)), keeping dose heterogeneity low ([Formula: see text] Gy(RBE)). The mean lung dose was kept lowest by the WEPL strategy, as well as the maximum dose to organs at risk (OARs). The impact on dose levels in the heart, spinal cord and esophagus were patient specific. Overall, the WEPL strategy gives the best performance and should be preferred when using a 3D static geometry for lung cancer IMPT treatment planning. Newly available fast MC methods make it possible to handle long simulations based on 4D data sets to perform studies with high accuracy and efficiency, even prior to individual treatment planning.

Indexed as

MovementCarcinoma, Non-Small-Cell LungHumansLung NeoplasmsMonte Carlo MethodOrgans at RiskProton TherapyRadiotherapy DosageRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedRetrospective StudiesTumor Burden

Identifiers

PMID29219119
PMCPMC5850956
OpenAlexW2771240168

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.